Phillip Mertz
Direktor/Vorstandsmitglied bei ALPHA COGNITION INC.
Vermögen: 621 632 $ am 30.04.2024
Aktive Positionen von Phillip Mertz
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ALPHA COGNITION INC. | Direktor/Vorstandsmitglied | 22.03.2021 | - |
Karriereverlauf von Phillip Mertz
Ehemalige bekannte Positionen von Phillip Mertz
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Alpha Cognition, Inc. /old/
 Alpha Cognition, Inc. /old/ Pharmaceuticals: MajorHealth Technology Alpha Cognition, Inc. engages in operation of a biopharmaceutical company focused on the development of novel therapies to treat diseases of the brain and spinal cord. It also provides research programs to find alternative ways of treating Alzheimer’s disease and Amyotrophic Lateral Sclerosis (ALS). The company is headquartered in Vancouver, Canada. | Direktor/Vorstandsmitglied | - | - |
Ausbildung von Phillip Mertz
| Harvard University | Undergraduate Degree |
Statistik
International
| Kanada | 3 |
| Vereinigte Staaten | 2 |
Operativ
| Director/Board Member | 3 |
| Founder | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ALPHA COGNITION INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Alpha Cognition, Inc. /old/
Alpha Cognition, Inc. /old/ Pharmaceuticals: MajorHealth Technology Alpha Cognition, Inc. engages in operation of a biopharmaceutical company focused on the development of novel therapies to treat diseases of the brain and spinal cord. It also provides research programs to find alternative ways of treating Alzheimer’s disease and Amyotrophic Lateral Sclerosis (ALS). The company is headquartered in Vancouver, Canada. | Health Technology |
- Börse
- Insiders
- Phillip Mertz
- Erfahrung
